MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Interventions"

  • 2023 International Congress

    How do people with Parkinson’s disease experience self-optimization of treatment using digitally supported symptom monitoring?

    K. Fåglum, A. Hjorth, M. Christani, P. Hagell, A. Ozanne, F. Bergquist (Varberg, Sweden)

    Objective: The aim of this study was to investigate how people with Parkinson´s disease experience an intervention of optimizing their own medical treatment through digitally…
  • 2023 International Congress

    Feasibility and acceptability of implementing dignity therapy as a supportive intervention for people with movement disorders.

    D. Labuschagne, J. Fleisher, K. Woo, G. Fitchett (Chicago, USA)

    Objective: To determine the feasibility and acceptability of implementing Dignity Therapy (DT) in a neuropalliative clinic, and to determine preliminary efficacy. Background: Awareness of the…
  • 2023 International Congress

    Is working memory training success in Parkinson’s disease determined by cortical thickness and white matter lesions?

    K. Giehl, H. Theis, A. Ophey, J. Hammes, P. Reker, C. Eggers, E. Kalbe, T. van Eimeren (Cologne, Germany)

    Objective: We aimed to evaluate the influence of cortical thickness (CT) and white matter lesions (WML) on working memory training (WMT) success in cognitively unimpaired…
  • 2023 International Congress

    Understanding patient perceptions of advanced Parkinson’s disease (aPD) treatments

    J. Domingos, R. Pahwa, A. Antonini, I. Malaty, S. Lindvall, F. de Renzis, C. Yan, K. Pantiri, N. Touba, E. Evans, A. Alobaidi, A. Shewale, M. Shah, P. Kukreja, J. Zamudio, K. Chaudhuri (Orpington Kent, United Kingdom)

    Objective: To explore patients’ perceptions of treatment options for aPD and treatment decision considerations. Background: As PD advances, some people with Parkinson’s (PwP) on oral…
  • 2023 International Congress

    Serotonin Coma: An Antipodal emergency

    K C. Chudasama, V J. Jhala (Rajkot, India)

    Objective: To highlight the severity of Serotonin syndrome precipitated in a Psychiatric patient on two unique serotonergic medications leading to a comatose state. Background: Serotonin…
  • 2023 International Congress

    Movement Disorders (MD) Specialist Nurse pilot project in Australia’s Northern Territory (NT): One year of experience.

    Y. Hernandez Gomez (Darwin, Australia)

    Objective: The MD Specialist Nurse, a project funded by the Commonwealth of Australia started 1 year ago to provide access to specialist nursing care and…
  • 2023 International Congress

    Chinese proprietary medicine as adjunct treatment for Parkinson’s disease: a systematic review and meta-analysis

    S. Yuen, KK. Chua, SC. Chen, CP. Ho, C. Chan, M. Li (Hong Kong, Hong Kong)

    Objective: To evaluate the effectiveness of Chinese proprietary medicine (CPM) in improving outcomes of Parkinson’s disease (PD). Background: CPM is a finished Chinese herbal medicine…
  • 2023 International Congress

    Non-intrusive Video-Based Solution for Continuous Quantitative Monitoring of Parkinson’s Patients’ Motor Functions

    A-S. Bridoux, G. Altares, G. Garraux, M. Koivu, L. Mäkitie, E. Fiorenzato, L. Weis, A. Antonini, A. Nieuwboer (Mons, Belgium)

    Objective: Feasibility and preliminary validation of a marker-less solution for automatic capture and quantification of movements during prespecified tasks of people with Parkinson’s (PwP) using…
  • 2023 International Congress

    Be aware of Involuntary Emotional Expressive Disorder: a neurological syndrome, not a mood disorder

    V. Balasubramaniam, L. Baytieh (WOLLONGONG, Australia)

    Objective: To increase awareness of Involuntary Emotional Expressive Disorder (IEED) in clinicians assessing patients affected with involuntary laughter and/or crying variants (in stroke and traumatic…
  • 2022 International Congress

    To Prescribe or Not to Prescribe: Assessing the impact of Parkinson’s nurse prescribers

    A. Hand, K. Mcewan, A. Clarke, A. Bate, S. Dalkin, R. Bradford, C. Allen, K. Mcdonald, S. Mccarthy, K. Brittain (Newcastle upon Tyne, United Kingdom)

    Objective: Within the UK, after successful completion of a formally recognised programme Parkinson’s Nurse Specialists (PNS) can act as independent prescribers, and as part of…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 23
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #25676 (not found)
  • Crack Dancing: An Uncommon Drug-Induced Chorea
  • #24376 (not found)
  • An atypical and interesting feature of Parkinson´s disease
  • A Case of Pregabalin induced Parkinsonism
  • A survey-based analysis of abnormal movements in patients with Postural Tachycardia Syndrome (PoTS)
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley